Nagasaki, Japan

Masahiro Ono

This inventor holds 1 USPTO granted patent. Top assignee: Nagasaki University. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiro Ono. Retrieved from https://idiyas.com/inventor/masahiro-ono-3fmvuhe4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masahiro Ono: Innovator in Diagnosing Amyloid-Related Diseases

Introduction

Masahiro Ono is a prominent inventor based in Nagasaki, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the area of amyloid-related diseases. His innovative work has the potential to enhance the accuracy of disease diagnosis, which is crucial for effective treatment.

Latest Patents

Masahiro Ono holds a patent for a composition designed for diagnosing amyloid-related diseases. This composition includes a flavone derivative, a chalcone derivative, a styrylchromone derivative, or a coumarin derivative. These compounds exhibit high binding specificity to amyloid β protein, high permeability to the blood-brain barrier, and the ability to rapidly disappear from sites other than cerebral senile plaque. Consequently, this composition enables the diagnosis of amyloid-related diseases with high precision.

Career Highlights

Ono is affiliated with Nagasaki University, where he continues to advance his research and innovation in the medical field. His work is characterized by a commitment to improving diagnostic methods and patient outcomes.

Collaborations

Masahiro Ono has collaborated with notable colleagues, including Hiroshi Mori and Morio Nakayama. These partnerships have fostered a collaborative environment that enhances the research and development of innovative diagnostic solutions.

Conclusion

Masahiro Ono's contributions to the diagnosis of amyloid-related diseases exemplify the impact of innovation in medicine. His work not only advances scientific understanding but also holds promise for improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…